Joanna Kolodney, MD, has joined WVU’s Department of Medicine and Cancer Institute. Dr. Kolodney practiced hematology/oncology at Lewis-Gale Hospital in Salem, VA, and was an assistant professor at Edward Via College of Osteopathic Medicine in Blacksburg, VA. She will see patients diagnosed with benign blood disease, melanoma, and lung, head and neck, gastrointestinal and genitourinary cancers.
Her husband, Michael Kolodney, MD, PhD, recently joined WVU Medicine Dermatology as the section’s new chief.
The WVU Cancer Institute held its annual Pink Party event on Monday, September 10, to benefit Bonnie’s Bus, the mobile mammography unit that travels across West Virginia to provide mammograms to the women of the state.
WVU Cancer Institute offering groundbreaking treatment for gastroenteropancreatic neuroendocrine tumors
The WVU Cancer Institute is participating in the implementation of a new drug therapy for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a type of tumor that can form in the pancreas or in other parts of the gastrointestinal tract, including the stomach, small intestine, colon, rectum, and appendix. These life-threatening tumors can spread to other organs, such as the liver.
Meshea Poore, vice president for the Division of Diversity, Equity and Inclusion at WVU, will be the special guest at a Health Sciences Town Hall during WVU’s Diversity Week celebrations.